|
R&D Systems
anti cd3ε antibody Anti Cd3ε Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti cd3ε antibody/product/R&D Systems Average 94 stars, based on 1 article reviews
anti cd3ε antibody - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti cd3 apc Anti Cd3 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti cd3 apc/product/Miltenyi Biotec Average 94 stars, based on 1 article reviews
anti cd3 apc - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Proteintech
1 ap 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/1 ap/product/Proteintech Average 96 stars, based on 1 article reviews
1 ap - by Bioz Stars,
2026-02
96/100 stars
|
Buy from Supplier |
|
R&D Systems
anti human cd3 ![]() Anti Human Cd3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti human cd3/product/R&D Systems Average 93 stars, based on 1 article reviews
anti human cd3 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
R&D Systems
anti clec5a mab ![]() Anti Clec5a Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti clec5a mab/product/R&D Systems Average 94 stars, based on 1 article reviews
anti clec5a mab - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
rea1151 ![]() Rea1151, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rea1151/product/Miltenyi Biotec Average 94 stars, based on 1 article reviews
rea1151 - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti cd3 ![]() Anti Cd3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti cd3/product/Miltenyi Biotec Average 95 stars, based on 1 article reviews
anti cd3 - by Bioz Stars,
2026-02
95/100 stars
|
Buy from Supplier |
|
Sino Biological
cd3 antibody ![]() Cd3 Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd3 antibody/product/Sino Biological Average 94 stars, based on 1 article reviews
cd3 antibody - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
pe miltenyi 130 113 139 cd4 ![]() Pe Miltenyi 130 113 139 Cd4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pe miltenyi 130 113 139 cd4/product/Miltenyi Biotec Average 94 stars, based on 1 article reviews
pe miltenyi 130 113 139 cd4 - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
rea613 1ul 2e5 cells cd19 fitc miltenyi ![]() Rea613 1ul 2e5 Cells Cd19 Fitc Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rea613 1ul 2e5 cells cd19 fitc miltenyi/product/Miltenyi Biotec Average 95 stars, based on 1 article reviews
rea613 1ul 2e5 cells cd19 fitc miltenyi - by Bioz Stars,
2026-02
95/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd3 ![]() Cd3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd3/product/Miltenyi Biotec Average 95 stars, based on 1 article reviews
cd3 - by Bioz Stars,
2026-02
95/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
rea613 130 113 136 t8sen cd3 pe vio615 miltenyi biotec ![]() Rea613 130 113 136 T8sen Cd3 Pe Vio615 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rea613 130 113 136 t8sen cd3 pe vio615 miltenyi biotec/product/Miltenyi Biotec Average 95 stars, based on 1 article reviews
rea613 130 113 136 t8sen cd3 pe vio615 miltenyi biotec - by Bioz Stars,
2026-02
95/100 stars
|
Buy from Supplier |
Image Search Results
Journal:
Article Title: T cell-mediated vascular dysfunction of human allografts results from IFN-? dysregulation of NO synthase
doi: 10.1172/JCI200421767
Figure Lengend Snippet: Effects of allogeneic T cells on arterial graft function at 1 week in vivo. Transplanted human arterial segments were recovered from mice injected with saline (open squares) or PBMCs (filled squares) 7–9 days before harvest (n = 5 pairs from four experiments). (A–D) Response curves. Restriction response to various concentrations of PGF2α (A) and relaxation response curves for nitroprusside (B), bradykinin (C), or substance P (D) after preconstriction with PGF2α. *P < 0.05; **P < 0.01; #P < 0.001 vs. saline control. mN, milliNewtons. (E) Immunohistochemistry of graft sections stained for human and murine (inset) CD31, human CD45, and HLA-DR. The staining for human CD45 is indistinguishable from that for human CD3 (data not shown). Original magnification, ×200.
Article Snippet: Immunostaining was performed as described ( 14 ) using the following primary mAb’s: mouse anti–human CD31, mouse anti–human HLA-DR (α-chain), and mouse anti–human CD45 (all from DAKO Corp.); mouse
Techniques: In Vivo, Injection, Saline, Control, Immunohistochemistry, Staining
Journal:
Article Title: T cell-mediated vascular dysfunction of human allografts results from IFN-? dysregulation of NO synthase
doi: 10.1172/JCI200421767
Figure Lengend Snippet: Effects of allogeneic T cells on arterial graft function at 2 weeks in vivo. Transplanted human arterial segments were recovered from mice injected with saline (open squares) or PBMCs (filled squares) for 13–15 days (n = 4–7 pairs from four to six experiments). (A–D) Response curves. Constriction response to various concentrations of PGF2α (A) and relaxation response to bradykinin (B), nitroprusside (C), or YC-1 (D) after preconstriction with PGF2α. *P < 0.05; **P < 0.01; #P < 0.001 vs. saline control. (E) Immunohistochemistry of graft sections stained for human and murine (inset) CD31, human CD3, and iNOS. iNOS expression was highly localized to infiltrating T cells (arrows). Original magnification: CD31 and CD3 panels, ×200; iNOS panels, ×400.
Article Snippet: Immunostaining was performed as described ( 14 ) using the following primary mAb’s: mouse anti–human CD31, mouse anti–human HLA-DR (α-chain), and mouse anti–human CD45 (all from DAKO Corp.); mouse
Techniques: In Vivo, Injection, Saline, Control, Immunohistochemistry, Staining, Expressing
Journal:
Article Title: T cell-mediated vascular dysfunction of human allografts results from IFN-? dysregulation of NO synthase
doi: 10.1172/JCI200421767
Figure Lengend Snippet: Effects of IFN-γ neutralization on T cell–mediated graft dysfunction in vivo. Transplanted human arterial segments were recovered from mice injected with saline alone (open squares) or PBMCs together with anti–IFN-γ mAb (filled triangles) or control mAb (IgG2a) (open triangles) for 2 weeks (n = 5 matched triplicates from three experiments). (A and B) Endothelium-independent responses to various concentrations of PGF2α (A) and nitroprusside (B). (C and D) Endothelium-dependent response to bradykinin before (C) and after (D) treatment with L-NAME. *P < 0.05; **P < 0.01; #P < 0.001 vs. PBMC + IgG2a group, n = 3–5. (E) Immunohistochemistry of graft sections stained for human CD3 and HLA-DR. The luminal HLA-DR–positive cells are also human CD31–positive (data not shown). Goat anti-mouse secondary Ab alone did not stain the grafts. Original magnification: CD3 panels, ×200; HLA-DR panels, ×400. (F and G) RNA transcript levels of iNOS (F) and eNOS (G) in whole tissue sections analyzed by quantitative RT-PCR.
Article Snippet: Immunostaining was performed as described ( 14 ) using the following primary mAb’s: mouse anti–human CD31, mouse anti–human HLA-DR (α-chain), and mouse anti–human CD45 (all from DAKO Corp.); mouse
Techniques: Neutralization, In Vivo, Injection, Saline, Control, Immunohistochemistry, Staining, Quantitative RT-PCR
Journal:
Article Title: T cell-mediated vascular dysfunction of human allografts results from IFN-? dysregulation of NO synthase
doi: 10.1172/JCI200421767
Figure Lengend Snippet: Effects of TNF neutralization on T cell–mediated graft dysfunction in vivo. Transplanted human arterial segments were recovered from mice injected with saline alone (open squares) or PBMCs together with anti-TNF mAb (filled triangles) or control mAb (IgG1) (open triangles) for 2 weeks (n = 4 matched triplicates from two experiments). (A–C) Concentration-dependent responses to PGF2α (A), nitroprusside (B), and bradykinin (C). *P < 0.05; **P < 0.01; #P < 0.001 vs. PBMC + IgG1 group; n = 3–4. (D) Immunohistochemistry of graft sections stained for human CD3 and HLA-DR. Original magnification: CD3 panels, ×200; HLA-DR panels, ×400. (E and F) RNA transcript levels of iNOS (E) and eNOS (F) in whole tissue sections analyzed by quantitative RT-PCR.
Article Snippet: Immunostaining was performed as described ( 14 ) using the following primary mAb’s: mouse anti–human CD31, mouse anti–human HLA-DR (α-chain), and mouse anti–human CD45 (all from DAKO Corp.); mouse
Techniques: Neutralization, In Vivo, Injection, Saline, Control, Concentration Assay, Immunohistochemistry, Staining, Quantitative RT-PCR
Journal: bioRxiv
Article Title: CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
doi: 10.1101/2022.02.01.478701
Figure Lengend Snippet: (a&b) Neutrophils (4 × 10 5 /ml) from healthy donors were incubated with SARS-CoV-2 (MOI = 1) with or without autologous platelets (4 × 10 6 /ml) for 5 h at 37 °C. The scale bar is 10 μm. The detailed structure of SARS-CoV-2-induced NET formation was observed under a confocal microscope (Leica). NET formation was visualized by fluorescent staining of DNA (blue), histone (green), and MPO (red) (a) . NETs level was measured by MetaMorph software and presented as Cit-H3 area (mm 2 ) (b) . (c) Human neutrophils (4 × 10 5 /ml) were pretreated with anti-hCLEC5A mAb (3E12A2, 100 μg/ml), anti-TLR2 mAb (# MAB2616, 100 μg/ml), or combination of both antibodies for 30 min at room temperature, followed by incubation with SARS-CoV-2 (MOI = 0.1 and 1) in the presence or absence of platelets (4 × 10 6 /ml) for 5 h and 20 h. The level of NET formation was determined by histone area (μm 2 ). (d) Neutrophils (4 × 10 5 /ml) from WT, clec5a -/- tlr2 -/- , and clec5a -/- tlr2 -/- mice were incubated with SARS-CoV-2 (MOI = 1) in the presence or absence of WT platelets (4 × 10 6 /ml) for 5 h at 37 °C. (e) Human neutrophils were pre-treated with anti-hCLEC5A mAb (3E12A2, 100 μg/ml), anti-TLR2 mAb (# MAB2616, 100 μg/ml), or combination of both antibodies for 30 min at room temperature, followed by incubation with SARS-CoV-2 spike pseudotyped virus (MOI = 0.1) in the presence or absence of autologous platelets (4 × 10 6 /ml) for 3 h. Data are mean ± SEM and repeats of 3 to 5 independent experiments. *p<0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (Student’s t-test).
Article Snippet: For blocking assay, neutrophils were preincubated with isotype (100 μg/ml),
Techniques: Incubation, Microscopy, Staining, Software, Virus
Journal: bioRxiv
Article Title: CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
doi: 10.1101/2022.02.01.478701
Figure Lengend Snippet: (a) EVs from healthy controls (HCs-EVs, n=5) and COVID-19 patients (COVID19-EVs, n=5) were harvested by ultracentrifugation, then lysed in RIPA solution before subjected to mass spectrometry analysis. Proteins expressed in COVID-19 EVs, but not in HCs EVs, were further analyzed using the QIAGEN Ingenuity Pathway Analysis (QIAGEN IPA) software. Proteins which were expressed in all the COVID19-EVs were displayed. (b&c) HCs-EVs (n=10) and COVID19-EVs (n=10) were analyzed by flow cytometry, and markers highly activated in COVID-19 platelets were expressed as a heat map (b) or by mean fluorescence intensity (c) . (d) Neutrophils were pre-incubated with anti-CLEC5A mAb (3E12A2, 100 μg/ml), anti-TLR2 mAb (# MAB2616, 100 μg/ml), or both anti-CLEC5A mAb (3E12A2, 100 μg/ml) and anti-TLR2 mAb (# MAB2616, 100 μg/ml), for 30 min at room temperature, followed by incubation with EVs (1 μg/ml) from COVID-19 patients (n=6) at 37°C for 3 h. Data are mean ± sd and repeats of at least three independent experiments. * p <0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (Student’s t -test).
Article Snippet: For blocking assay, neutrophils were preincubated with isotype (100 μg/ml),
Techniques: Mass Spectrometry, Software, Flow Cytometry, Fluorescence, Incubation
Journal: bioRxiv
Article Title: CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
doi: 10.1101/2022.02.01.478701
Figure Lengend Snippet: C57BL/6 mice (WT) (n=3) and clec5a -/- tlr2 -/- mice (n=3)were inoculated with AAV-hACE2 for 14 days, followed by intranasal inoculation of SARS-CoV-2 (8 × 10 4 PFU/per mice). Tissues were collected at 3 days and 5 days post-infection. (a) The level of proinflammatory cytokines and chemokines were measured by real-time PCR and presented as fold change (compared to AAV-hACE2 uninfected mice/mock). ( b-d) NET structure and thrombus were detected by Hoechst. 33342 (blue), anti-MPO antibody (green), anti-citrullinated histone H3 (red), anti-CD42b antibody (yellow) (b) , and images were captured by a confocal microscope and subjected to determine the area of MPO (c) and CD42b (d) using MetaMorph TM software. (e) Cell infiltrated to lung. Interstitial macrophage (interstitial MΦ) was defined as CD11b + CD64 + F4/80 + cells; monocyte-derived dendritic cell (DC)/macrophage (MΦ) was defined as CD11b + CD64 + Ly6C + ; Ly6C + monocyte was defined as Ly6C + . The cell number of each cell population was calculated using the multiple fluorescent staining image and analyzed by software MetaMorph TM , and the data was presented as cell number/ per 664225 (815 × 815). Scale bar is 200 μm. Data are represented as mean ± SEM. * p <0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (Student’s t -test).
Article Snippet: For blocking assay, neutrophils were preincubated with isotype (100 μg/ml),
Techniques: Infection, Real-time Polymerase Chain Reaction, Microscopy, Software, Derivative Assay, Staining
Journal: Frontiers in Immunology
Article Title: Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging
doi: 10.3389/fimmu.2024.1383932
Figure Lengend Snippet: Immunophenotyping panel for multiplexed tissue imaging of cancer.
Article Snippet: CD3 ,
Techniques: Imaging